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ABSTRACT 
Objective: Plants of genus Bauhinia are famous for their rich flavonoid content. Several phytochemical and biological investigations affirmed the 
role of flavonoids in the different biological impacts exerted by Bauhinia plants. The present study aims to investigate the major phytoconstituents 
of the leaves of B. vahlii Wight and Arnott.  
Methods: Powdered leaves were extracted with n-hexane (HE) and the defatted marc was extracted with 70% ethanol. The defatted ethanolic 
extract (DEE) was further partitioned with solvents of increasing polarities. The HE and polar fractions of DEE were purified using different 
chromatographic techniques and isolated compounds were identified through their melting points, 1D and 2D NMR, UV and MS spectral data.  
Results: A total of nine compounds were isolated and identified. Taraxerol (1), a pentacyclic triterpene, and β-sitosterol (2) were isolated from HE. 
Investigation of polar fractions of DEE yielded six flavonoids and a phenolic acid, namely luteolin (3), quercetin (4), gallic acid (5), avicularin (6), 
quercitrin (7), hyperoside (8) and quercetin-3-O-β-sophoroside (9). 
Conclusion: Flavonols of the quercetin nucleus were the major detected constituents in B. vahlii leaves. Taraxerol, avicularin and quercetin-3-O-β-
sophoroside are isolated for the first time from the genus Bauhinia. Results of this study encourage future pharmacological investigation of B. vahlii 
due to the presence of biologically active flavonoids and phytosterols. 
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INTRODUCTION 
Bauhinia (family Fabaceae) is a genus of trees or shrubs widely 
distributed in the tropical and subtropical regions of Africa, Asia and 
South America. Plants of the genus Bauhinia are commonly known 
as “cow’s paw” or “camel’s foot” because of the characteristic shape 
of their leaves. The leaves and stem barks have been used in folk 
medicine of some countries as remedies for the treatment of 
different health conditions including diabetes, pain and some 
inflammatory disorders [1]. 
Due to their presumed therapeutic value, several species of the 
genus Bauhinia were chemically investigated with the leaf being the 
more thoroughly studied organ [1]. Reports regarding the main 
secondary metabolites in Bauhinia species indicated the presence of 
flavonoids, terpenes, sterols, aromatic acids, saponins, oxepins, 
tannins, bibenzyls and alkaloids with flavonoids identified as the 
major class of secondary metabolites [1, 2]. 
Several investigations of B. variegata, one of the famous Bauhinia 
plants, resulted in the isolation of a wide range of flavonoid 
aglycones and glycosides [3-6]. From B. malabarica seven flavonols 
were identified as kaempferol, quercetin and their glycosides [7]. 
Also, different quercetin and kaempferol derivatives were isolated 
from B. forficata leaves and flowers [8]. Additionally, Neto et al. 
reported the isolation of quercetin, guaijaverin and quercitrin from 
the leaves of B. ungulata [2]. 
Bauhinia vahlii Wight and Arnott. is a huge climber native to India 
with only few reports that can be traced concerning its main 
secondary metabolites. Sultana et al. reported the isolation of 
agathisflavone, quercetin, kaempferol, isoquercitrin, campesterol, 
stigmasterol and β-sitosterol from the leaves acetone extract [9]. In 
addition, Kumar RJ et al. isolated (+)-catechin, methyl gallate and 
methyl-4-O-methyl gallate from the pericarps of the fruits [10]. 
In this study, the leaves of B. vahlii were subjected to a deeper 
chemical investigation of their major phytoconstituents that might 
help in predicting their possible therapeutic impacts.  
MATERIALS AND METHODS 
Plant material 
Samples of B. vahlii leaves were collected during the flowering stage 
in May 2013 from the garden of Mohammed Ali museum, Kasr Al-
Aini, El-Manial, Egypt. The identity of the leaves was authenticated 
by Dr. Mohammed El-Gebaly, senior botanist at National Research 
Center, Giza, Egypt. A voucher specimen (No. 11-6-2013s-1) was 
kept at the Herbarium of Pharmacognosy Department, Faculty of 
Pharmacy, Cairo University. 
Preparation of plant extracts and fractions 
Air-dried powdered B. vahlii leaves (2.9 kg) were extracted 
exhaustively with n-hexane and the extracts were combined and 
evaporated under reduced pressure yielding the n-hexane extract 
(HE). The defatted leaves were then extracted with 70% ethanol till 
exhaustion and the combined extracts were evaporated under 
reduced pressure yielding defatted ethanolic extract (DEE). DEE was 
suspended in distilled water and partitioned successively with 
solvents of increasing polarities; dichloromethane, ethyl acetate and 
n-butanol saturated with water yielding their corresponding DCM, 
EtOAc and BuOH fractions, respectively. 
Chemicals 
Authentic reference samples used in co-chromatography were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). Diaion HP-
20 AG for column chromatography was obtained from Mitsubishi 
Chemical Industries Co. Ltd, Japan. Silica gel H 60 for vacuum liquid 
chromatography (VLC) was purchased from E-Merck (Darmstadt, 
Germany). Silica gel 60 and silica gel RP-18 for column 
chromatography were obtained from Fluka, Sigma-Aldrich 
Chemicals, Germany. Sephadex LH-20 was purchased from 
Pharmacia Fine Chemicals AB (Uppsala, Sweden). Precoated TLC 
plates and silica gel 60 F 254 was obtained from Fluka, Sigma-
Aldrich Chemicals, Germany. The chromatograms were visualized 
under UV light (at 254 and 366 nm) before and after exposure to 
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ammonia vapor, as well as spraying with p-anisaldehyde/sulfuric 
acid [11] and/or natural products/polyethylene glycol (NP/PEG) 
spray reagents [12]. 
Apparatus and equipment  
Schimadzu double beam spectrophotometer (UV-1650, Japan) was 
utilized for determination of UV shifts of flavonoids. Mass spectra 
were studied using Thermo scientific ISQLT single quadrupole, USA. 
NMR spectra were recorded at 400 (1H) and 100 MHz (13C) on a 
Bruker NMR-spectrometer, Japan. The NMR spectra were recorded 
in deuterated CH3OH, CHCl3 or CH3COCH3 using TMS as an internal 
standard. Electrothermal 9100 (Labequip, Markham, Ontario, 
Canada) was used for determination of melting points (m. p.) 
(uncorrected). 
Phytochemical investigation of plant extractives 
n-Hexane extract 
The n-hexane extract (20 g) was chromatographed on a VLC column 
(Silica gel H 60, 300 g, 16 D x 7 L cm). Elution was performed 
gradually using n-hexane, n-hexane/DCM mixtures, and DCM/EtOAc 
mixtures. Collected fractions (300 ml each) were monitored by TLC 
and those with the similar chromatographic pattern were pooled 
together. Fraction eluted with 100% DCM was chromatographed on 
a silica gel 60 column (2.5 D x 25 L cm) using n-hexane/EtOAc 
mixture (98:2) as an eluent to yield compound 1 (30 mg). Fractions 
eluted with 20-30% EtOAc in DCM were combined and 
chromatographed on a silica gel 60 column (3 D x 30 L cm) using n-
hexane/DCM (10:90) to yield compound 2 (90 mg). 
Ethyl acetate fraction 
The fraction (10 g) was chromatographed on a VLC column (Silica 
gel H 60, 190 g, 12.5 D x 7 cm L). Gradient elution was performed 
starting with DCM, DCM/EtOAc mixtures, and EtOAc/methanol 
mixtures. Fractions were collected (300 ml each) and monitored by 
TLC and similar ones were pooled yielding nine fractions designated 
as fractions I-IX. Fraction II (eluted with 50-70% EtOAc in DCM) was 
chromatographed on a sephadex LH-20 column using 
methanol/water (20:80) v/v as an eluent to yield 2 compounds; 3 
(15 mg) and 4 (90 mg). Fraction III (eluted with 80% EtOAc in DCM) 
was chromatographed on a sephadex LH-20 column using 
methanol/water (50:50) v/v for elution to yield compound 5 (25 
mg). Fraction V (eluted with 100% EtOAc) was chromatographed on 
a sephadex LH-20 column using methanol/water (50:50) v/v as an 
eluent yielding 2 compounds; 6 (24 mg) and 7 (165 mg). Finally, 
fraction VII (eluted with 5-15 % methanol in EtOAc) was 
chromatographed on a VLC silica gel RP-18 column (2 D X 20 L cm) 
using methanol/water gradient elution with 5% increments of 
methanol. Subfractions eluted with 15-20% methanol in water were 
pooled and chromatographed on a sephadex LH-20 column using 
methanol/water (50:50) v/v for elution to yield compound 8 (12 
mg). 
n-Butanol fraction 
The fraction (15 g) was dissolved in water and chromatographed on 
a Diaion HP-resin column (4 D x 30 L cm). Successive elution was 
performed starting with water followed by 25% and 50% methanol 
in water and finally 100% methanol. Fractions eluted with 50 and 
100% methanol in water showed similar pattern on TLC and were 
pooled together. This collective fraction was further 
chromatographed on a polyamide column (5 D x 15 L cm) using 
gradient elution with methanol/water mixtures with 10% 
increments of methanol. Sub fractions eluted with 30-40% methanol 
in water were pooled and further purified on a sephadex LH-20 
column (1 D x 10 L cm) using methanol/water (50:50) v/v as an 
eluent to yield compound 9 (10 mg). 
Analysis of isolated compounds 
Compound 1 
White powder, m. p. = 276-278 °C, 1H-NMR (400 MHz, CDCl3, ppm, 
J/Hz): 0.79 (3H, s, CH3-24), 0.81 (3H, s, CH3-28), 0.9 (6H, s, CH3-26, 
30), 0.92 (3H, s, CH3-25), 0.95 (3H, s, CH3-29), 0.97 (3H, s, CH3-23), 
1.08 (3H, s, CH3-27), 3.19 (1H, dd, J = 11.16, 4.7 Hz, H-3), 5.53 (1H, 
dd, J = 8.16, 3.2 Hz, H-15).13C-NMR (100 MHz, CDCl3, ppm): 37.3 (C-
1), 27 (C-2), 79.13 (C-3), 38.5 (C-4), 55.5 (C-5), 18.4 (C-6), 34.1 (C-7), 
36.69 (C-8), 49.11 (C-9), 37.6 (C-10), 16.48 (C-11), 34.77 (C-12), 
37.74 (C-13), 158.11 (C-14), 116.84 (C-15), 35.66 (C-16), 38.8 (C-
17), 48.57 (C-18), 40.3 (C-19), 28.34 (C-20), 32.68 (C-21), 36.4 (C-
22), 28 (C-23), 15.2 (C-24), 15.4 (C-25), 29.8 (C-26), 25.9 (C-27), 
29.72 (C-28), 32.9 (C-29), 21.23 (C-30). EI/MS m/z (70 ev): 426 (M+., 
C30H50O, 3%), 302 (M+.-C9H16, 43%), 287 (M+.-C10H19, 53%), 204 (M+.-
C15H26O, 100%). 
Compound 2 
White powder, m. p. = 140-140 °C, 1H-NMR (400 MHz, CDCl3, ppm, 
J/Hz): 0.71 (3H, d, J = 7.2, CH3-21), 0.85 (3H, t, J = 5.6, CH3-29), 0.87 
(3H, d, J = 5.5, CH3-26), 0.88 (3H, s, CH3-18), 0.94 (3H, d, J = 6.4, CH3-
27), 1.03 (3H, s, CH3-19), 3.55 (1H, m, H-3), 5.37 (1H, d, J = 4, H-6). 
EI/MS m/z (70 ev): 414 (M+., C29H50O, 47%), 396 (M+.-H2O, 30%), 
273 (M+.-side chain-2H, 40%), 255 (M+.-side chain-H2O, 58%).  
Compound 3 
Yellow powder, m. p. = 329-330 °C, 1H-NMR (400 MHz, CD3OCD3, 
ppm, J/Hz): 6.22 (1H, d, J = 2 Hz, H-6), 6.48 (1H,, d, J = 1.96 Hz, H-8), 
6.69 (1H, s, H-3), 6.92 (1H, d, J = 8 Hz, H-5'), 7.45 (1H, dd, H-2', H-6', 
partially overlapping).  
Compound 4 
Yellow powder, m. p. = 315-317 °C, 1H-NMR (400 MHz, CD3OCD3, 
ppm, J/Hz): 6.13 (1H, d, J = 2 Hz, H-6), 6.39 (1H, d, J = 2 Hz, H-8), 6.86 
(1H, d, J = 8.5 Hz, H-5'), 7.56 (1H, dd, J = 2, 8.5 Hz, H-6'), 7.68 (1H, d, J 
= 2 Hz, H-2'). 
Compound 5 
White needle crystals that gives dark blue color with FeCl3, m. p. = 
256 °C, 1H-NMR (400 MHz, CD3OCD3, ppm, J/Hz): 6.92 (2H, s, H-2 and 
6), 9.16 (3H, br. s, OH-3, 4, 5), 12.1 (1H, br. s, COOH).  
Compound 6 
Yellow powder, m. p. = 240-243 °C, 1H-NMR (400 MHz, CD3OD, ppm, 
J/Hz): 6.2 (1H, d, J = 2 Hz, H-6), 6.39 (1H, d, J = 2 Hz, H-8), 6.89 (1H, d, 
J = 8.4 Hz, H-5'), 7.49 (1H, dd, J = 2.2, 8.2 Hz, H-6'), 7.52 (1H, d, J = 2.1 
Hz, H-2'), 5.46 (1H, br. s, H-1''), 3.49-4.33 (sugar protons). 13C-NMR 
(100 MHz, CD3OD, ppm): 157.3 (C-2), 133.47 (C-3), 178.59 (C-4), 
161.73 (C-5), 98.57 (C-6), 164.96 (C-7), 93.36 (C-8), 158 (C-9), 
104.25 (C-10), 121.9 (C-1'), 115.7 (C-2'), 144.94 (C-3'), 148.4 (C-4'), 
114.9 (C-5'), 121.61 (C-6'), 108.21 (C-1''), 77.27 (C-2''), 81.98 (C-3''), 
86.66 (C-4''), 61.4 (C-5'').  
Compound 7 
Yellow powder, m. p. = 182-185 °C, 1H-NMR (400 MHz, CD3OD, ppm, 
J/Hz): 6.19 (1H, d, J = 2 Hz, H-6), 6.36 (1H, d, J = 2 Hz, H-8), 6.9 (1H, d, 
J = 8.3 Hz, H-5'), 7.3 (1H, dd, J = 2, 8.3 Hz, H-6'), 7.33 (1H, d, J = 2 Hz, 
H-2'), 5.35 (1H, d, J =1.2 Hz, H-1''), 0.94 (3H, d, J = 6 Hz, H-6''), 3.33-
4.21 (sugar protons). 13C-NMR (100 MHz, CD3OD, ppm): 157.1 (C-2), 
134.8 (C-3), 178.21 (C-4), 161.78 (C-5), 98.39 (C-6), 164.5 (C-7), 
93.39 (C-8), 157.87 (C-9), 104.46 (C-10), 121.54 (C-1'), 115.5 (C-2'), 
145 (C-3'), 148.36 (C-4'), 114.93 (C-5'), 121.43 (C-6'), 102.11 (C-1''), 
70.6 (C-2''), 70.71(C-3''), 71.84 (C-4''), 70.48 (C-5''), 16.22 (C-6'').  
Compound 8 
Yellow powder, m. p. = 215-217 °C, 1H-NMR (400 MHz, CD3OD, ppm, 
J/Hz): 6.1 (1H, d, J = 2 Hz, H-6), 6.28 (1H, d, J= 2 Hz, H-8), 6.76 (1H, d, 
J = 8 Hz, H-5'), 7.48 (1H, dd, J = 2, 8 Hz, H-6'), 7.74 (1H, d, J = 2 Hz, H-
2'), 5.05 (1H, d, J = 8 Hz, H-1''), 3.3-4.7 (sugar protons).13C-NMR (100 
MHz, CD3OD, ppm): 157.42 (C-2), 134.52 (C-3), 178.11 (C-4), 161.69 
(C-5), 98.97 (C-6), 165.65 (C-7), 93.73 (C-8), 157.2 (C-9), 104.14 (C-
10), 121.1 (C-1'), 116.37 (C-2'), 144.46 (C-3'), 148.73 (C-4'), 114.86 
(C-5'), 121.6 (C-6'), 103.94 (C-1''), 71.77 (C-2''), 73.75 (C-3''), 68.83 
(C-4''), 75.78 (C-5''), 60.58 (C-6'').  
Compound 9 
Yellow powder, m. p. = 198-200 °C, 1H-NMR (400 MHz, CD3OD, ppm, 
J/Hz): 6.17 (1H, d, J = 2 Hz, H-6), 6.37 (1H, d, J = 2 Hz, H-8), 6.87 (1H, 
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d, J = 8.5 Hz, H-5'), 7.55 (1H, dd, J= 2.2, 8.4 Hz, H-6'), 7.73 (1H, d, J = 
2.2 Hz, H-2'), 5.24 (1H, d, J = 7.6 Hz, H-1''), 4.75 (1H, d, J = 7.3 Hz, H-
1''') 3.3-4.1 (sugar protons).13C-NMR (100 MHz, CD3OD, ppm): 156.3 
(C-2), 133.9 (C-3), 177.5 (C-4), 161.8 (C-5), 98.2 (C-6), 165 (C-7), 
93.1 (C-8), 156 (C-9), 104.3 (C-10), 121.2 (C-1'), 116 (C-2'), 145 (C-
3'), 148.6 (C-4'), 116.2 (C-5'), 122 (C-6'), 100 (C-1''), 79.8 (C-2''), 
75.7 (C-3''), 69.6 (C-4''), 77 (C-5''), 60.2 (C-6''), 103.9 (C-1'''), 74.5 
(C-2'''), 76.8 (C-3'''), 69.6 (C-4''), 76.9 (C-5''), 60.2 (C-6''). HSQC (δ 
H/C): 5.24, 100 (HC-1''), 4.75, 103.9 (HC-1''') and 4.1, 79.8 (HC-2''). 
HMBC (δ H/C): 5.24, 133.9 (H-1''→C-3), 4.75, 79.8 (H-1'''→C-2'') 
and 4.06, 103.9 (H-2''→C-1''').  
RESULTS AND DISCUSSION 
A total of nine compounds were successfully isolated from B. vahlii 
leaves extractives. Phytochemical study of HE resulted in isolation of 
2 compounds; a triterpene (compound 1) and a phytosterol 
(compound 2), while chemical investigation of both EtOAc and BuOH 
resulted in isolation of six flavonoids and one phenolic acid 
designated as 3-9 (fig. 1). The identities of these compounds were 




1H-NMR spectrum of compound 1 revealed the presence of eight 
methyl groups and a single olefinic proton appearing at δ 5.53 ppm. 
The characteristic signal for H-3 observed at δ 3.19 ppm (dd, J = 
11.16, 4.7 Hz) suggested the presence of a triterpene nucleus with 
one double bond and a single hydroxyl group at 3-position. HSQC 
spectrum of compound 1 showed the presence of eight methyl 
groups at δ H/C observed at (0.79,15.4), (0.81,29.6), (0.90,29.8), 
(0.90,21.2), (0.92,15.4), (0.95,33.2), (0.97,27.9) and (1.08,25.9) 
assigned for C-24, C-28, C-26, C-30, C-25, C-29, C-23 and C-27, 
respectively. Furthermore, analysis of HMBC spectrum of compound 
1 identified the resonance of the two oleifinic carbons at δ 158.1 and 
116.8 ppm characteristic for C-14 and C-15 double bond of taraxerol. 
The identification of compound 1 as taraxerol was confirmed 
through several HMBC correlations including 3H-26→C-14 and 3H-
27→C-14. The EI/MS spectrum of compound 1 further confirmed its 
identification as taraxerol by showing a molecular ion peak (M+.) at 
m/z 426 (3%) calculated for the molecular formula C30H50O in 
addition to the characteristic base peak at 204 [M+.-C15H26O] at 
100% intensity. These obtained spectral data of compound 1 also 
comply with the previously reported data of taraxerol [13].  
Compounds 2, 3, 4 and 5 were identified through their melting points, 
1H-NMR spectra and co-chromatography with authentic samples as β-
sitosterol, luteolin, quercetin and gallic acid, respectively. 
Compounds 6-8 were identified as quercetin-3-O-monosaccharides. 
The quercetin nucleus and the sugar moiety in each compound were 
concluded from their respective 1H and 13C-NMR spectral data. The 
3-O-glycosidation was confirmed by their UV spectral behavior in 
methanol and after addition of different UV shift reagents in addition 
to the upfield shift of their C-3 resonances [14]. Using co-
chromatography with authentic samples and upon a comparison of 
the spectral data with the available literature [15, 16], compounds 6, 
7 and 8 were identified as quercetin-3-O-α-arabinofuranoside 
(Avicularin), quercetin-3-O-α-rhamnopyranoside (Quercitrin) and 
quercetin-3-O-β-galactopyranoside (Hyperoside), respectively. 
1H and 13C-NMR spectra of compound 9 indicated it is a quercetin-3-
O-disaccharide. The presence of two sugar residues was inferred 
from the presence of two anomeric proton signals at 5.24 (1H, d, J = 
7.6 Hz) and 4.75 (1H, d, J = 7.3 Hz) with their corresponding carbons 
at δC 100 and 103.9. The 3-OH was confirmed to be the site of 
glycosidation through analysis of the HMBC spectrum of the 
compound which showed H-1''→C-3 correlation at (5.24, 133.9). 
Further analysis of the HMBC spectrum indicated the linkage 
between the two sugar moieties to be 1'''→2'' through the 
observation of H-1'''→C-2'' and H-2''→C-1''' correlations at δ H/C 
observed at (4.75, 79.8) and (4.06, 103.9), respectively. Comparing 
to published data [17], compound 9 was identified as quercetin-3-O-
β-glucosyl-(1→2)-β-glucoside (Quercetin-3-O-β-sophoroside). 
CONCLUSION 
Chemical investigation of the leaves of B. vahlii Wight and Arnott. 
grown in Egypt revealed that they are rich in flavonoids mainly of 
quercetin nucleus. The leaves n-hexane extract was also rich in 
phytosterols and triterpenes. To the best of our knowledge, this is the 
first report for the isolation of taraxerol, avicularin and quercetin-3-O-
β-sophoroside from genus Bauhinia, while luteolin, quercitrin, 
hyperoside and gallic acid are reported for the first time to be isolated 
from species B. vahlii. These findings come in agreement with previous 
reports indicated flavonoids, particularly flavonols, to be the dominant 
secondary metabolites in genus Bauhinia [1]. Our findings also 
encourage pharmacological investigation of different extracts of B. 
vahlii due to the presence of biologically active phytosterols, 
triterpenes, and flavonoids. Taraxerol and sterols are reported to 
possess anti-inflammatory action [13, 18], also accumulated reports 
revealed that biological impacts of many Bauhinia species are mainly 
related to their flavonoid content [1, 19, 20]. 
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